Analysts Set Hims & Hers Health, Inc. (NYSE:HIMS) Price Target at $19.86
Hims & Hers Health, Inc. (NYSE:HIMS – Get Free Report) has been given an average recommendation of “Moderate Buy” by the sixteen analysts that are presently covering the company, MarketBeat reports. Eight research analysts have rated the stock with a hold rating and eight have issued a buy rating on the company. The average twelve-month […]
More Stories
Worldquant Millennium Advisors LLC Boosts Stake in NVIDIA Co. (NASDAQ:NVDA)
Worldquant Millennium Advisors LLC increased its position in shares of NVIDIA Co. (NASDAQ:NVDA – Free Report) by 11.3% during the...
NVIDIA Co. (NASDAQ:NVDA) Shares Bought by US Financial Advisors LLC
US Financial Advisors LLC lifted its stake in NVIDIA Co. (NASDAQ:NVDA – Free Report) by 48.4% in the fourth quarter,...
UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Grows Position in SiTime Co. (NASDAQ:SITM)
UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC lifted its stake in SiTime Co. (NASDAQ:SITM –...
UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Has $8.80 Million Holdings in FirstCash Holdings, Inc. (NASDAQ:FCFS)
UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC cut its position in shares of FirstCash Holdings,...
Arvinas, Inc. (NASDAQ:ARVN) Shares Bought by UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC
UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC boosted its position in shares of Arvinas, Inc....
UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Purchases 63,573 Shares of StepStone Group LP (NASDAQ:STEP)
UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC raised its position in shares of StepStone Group...